업무사례

독점금지 및 남용

About

Understanding the IP issues helps minimize risk
Antitrust claims in the United States can lead to significant damages and compulsory licenses. Misuse claims raise many of the same issues as antitrust claims but, if successful, can result in unenforceability of patents, putting at risk the typically large investments made to develop and protect the inventions and income streams from those inventions.

Finnegan’s antitrust attorneys have extensive experience in intellectual property antitrust and misuse issues. They regularly provide guidance to clients to minimize the risks that arise in licensing, litigations, and settlements, and they are prepared to litigate.

The licensing of patents, particularly by industry leaders, routinely raises potential patent antitrust and misuse questions, which both licensors and licensees need to consider to minimize risks. These issues arise in the context of licensing programs for portfolios of patents, individual patents, and pooled patents. They also arise in patent litigations as claims or counterclaims, which can multiply the risks or rewards of the litigation.

Finnegan attorneys have litigated patent antitrust and misuse claims in the context of patent infringement litigations and as separate antitrust cases. In those litigations where some clients have chosen to work with their existing specialists for antitrust issues, Finnegan’s attorneys with expertise in both patent and antitrust law have provided the essential interface between both teams to best represent our clients.

Everyone in this practice

업무사례

Represented DuPont in patent and antitrust litigation in the District of Delaware against a direct competitor relating to chemical-mechanical polishing compositions.

1:20-cv-00738, D. Del., Judge Hall

Defended Philips from antitrust and contract claims relating to digital television broadcasting standards.

1:17-cv-00921, N.D.N.Y., Judges McAvoy, Peebles
18-2992, 2nd Cir.

Represented Senju in antitrust cases brought by Hartig related to gatifloxacin, settled on confidential terms.

1:14-cv-00719, D. Del., Judges Batallion, Fallon

Represented Senju in antitrust cases brought by Apotex related to gatifloxacin, settled on confidential terms.

1:12-cv-00196, D. Del., Judge Robinson

Secured favorable settlement of complex iris scanner technology litigation involving infringement, trade secret, contract, antitrust, unfair competition, and Foreign Corrupt Practices Act claims and counterclaims.

2:04-cv-00391, D.N.J., Judges Arleo, Wigenton

Finnegan has represented many healthcare companies in transactions that included strategic counseling on antitrust and patent misuse issues. For example, Finnegan counseled Applera in its strategic settlement with Roche concerning PCR technology.